Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is June 03, 2024.
All times in Eastern Daylight Time.
-
PUMA anuncia su asociación mundial con HYROXHERZOGENAURACH, Alemania--(BUSINESS WIRE)--La empresa deportiva mundial PUMA ha anunciado una asociación mundial con HYROX, la serie mundial de competencias de fitness. PUMA se convierte así en el ... more »
-
Cannabis Beverages Global Strategic Business Report 2024-2030: Alcoholic Beverage Companies Seek Role in the $3.8 Billion Market - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Cannabis Beverages - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Cannabis Beverages Market to Reach $3.8 Billi... more »
-
NEW YORK--(BUSINESS WIRE)--Focus Financial Partners Inc., a leading partnership of fiduciary wealth management and related financial services firms, announced today that five U.S.-based business li... more »
-
Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt SecuritiesNEW YORK--(BUSINESS WIRE)--Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of its Debt Securities more »
-
NEW YORK--(BUSINESS WIRE)--Focus Financial Partners Inc., a leading partnership of fiduciary wealth management firms and related financial services firms, announced today that the NorthCoast Asset ... more »
-
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologic intended to enhance regulatory T cell (Treg) f... more »
-
Bridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing StrategySALT LAKE CITY--(BUSINESS WIRE)--Bridge Investment Group Holdings Inc. (NYSE: BRDG) (“Bridge” or the “Company”) today announced Alison Brown will be joining the Company as President of Bridge Prope... more »
-
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024ANAHEIM, Calif.--(BUSINESS WIRE)--To help accelerate the promise of precision medicine, Thermo Fisher Scientific today unveiled its new solutions accelerating research workflows at the annual Ameri... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 31.05.2024 FEUZ IE00B8X9NY41 1,671,193.00 EUR 70,... more »
-
DEBIOPHARM ET GENOME & COMPANY CONCLUENT UN ACCORD POUR LE DÉVELOPPEMENT D’UNE FAMILLE DE CONJUGUÉS ANTICORPS-MÉDICAMENT ONCOLOGIQUES POTENTIELLEMENT « FIRST-IN-CLASS »LAUSANNE, Suisse & SUWON-SI GYEONGGI-DO, Corée du Sud--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), société biopharmaceutique indépendante basée en Suisse dont la vocation est de développer le... more »
-
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate FamilyLAUSANNE, Switzerland & SUWON-SI GYEONGGI-DO, South Korea--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 31.05.2024 FEM IE00B8X9NX34 425,002.00 US... more »
-
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancerPHILADELPHIA--(BUSINESS WIRE)--Jemperli trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced dMMR rectal cancer more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 31.05.2024 FEXD IE00BWTNMB87 580,444.00 ... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 31.05.2024 FEXU IE00B8X9NW27 542,906.00 ... more »